[{"Assets_0_FY_USD":1260803000.0,"CommonStockSharesOutstanding_0_FY_shares":20765533.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":194059000.0,"NetIncomeLoss_1_FY_USD":-7007000.0,"NetIncomeLoss_4_FY_USD":143321000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":21109000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":21160000.0,"StockholdersEquity_0_FY_USD":560914000.0,"EarningsPerShareBasic_4_FY_USD":6.77,"EarningsPerShareBasic_1_FY_USD":-0.33,"Ticker":"LGND","CIK":"886163","name":"LIGAND PHARMACEUTICALS INC","OfficialName":"Ligand Pharmaceuticals Incorporated Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1738856427.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190228"}]